Establishment and characterization of SRIK-NKL: A novel CD8+ natural killer/T cell line derived from a patient with leukemic phase of acute lymphoblastic lymphoma

Leukemia Research

Volumn 29, Issue 7, 2005, Pages 771-783

  Srivastava, Bejai I S ^a   Srivastava, Maya D ^b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Adhesion; CD8; Cytokine; Cytotoxicity; Leukemia; Natural killer cell; Receptor; Translocation

Indexed keywords

NATURAL KILLER CELL RECEPTOR NKG2D;

ADOLESCENT; ARTICLE; AUTOIMMUNE DISEASE; CANCER; CASE REPORT; CELL FUNCTION; CELL LINE; CELL MATURATION; COMPARATIVE STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE FUNCTION TEST; INFECTION; LEUKEMIA; LYMPHOBLASTOMA; MALE; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANTIGENS, CD; ANTIGENS, CD8; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; HUMANS; KILLER CELLS, NATURAL; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; PHENOTYPE;

EID: 20344386220     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2004.12.017     Document Type: Article

References (56)

1. J.P. Greer, M.C. Kinney, and T.P. Loughran Jr. T-cell and NK cell lymphoproliferative disorders Hematology (Am Soc Hematol Educ Program) 2001 259 281
2. K.L. Mc Queen, and P. Parham Variable receptors controlling activation and inhibition of NK cells Curr Opin Immunol 14 2002 615 621
3. D.C. Jones, and N.T. Young Natural killer receptor in transplantation Eur J Immunogenet 30 2003 159 176
4. N.T. Young, M. Uhrberg, J.H. Phillips, L.L. Lanier, and P. Parham Differential expression of leukocyte receptor complex-encoded Ig-like receptor correlates with the transition form effector to memory CTL J Immunol 166 2001 3933 3941
5. M. Yawata, N. Yawata, K.L. McQueen, N.W. Cheng, L.A. Guethlein, and R. Rajalingam Predominance of group A KIR haplotypes in Japanese associated with diverse NK cell repertoires of KIR expression Immunogenetics 54 2002 542 550
6. M.R. Vemeris, M. Karami, J. Baker, A. Jayaswal, and R.S. Negrin Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells Blood 103 2004 3065 3072
7. M. Vitale, M. Falco, R. Castriconi, S. Parolini, R. Zambello, and G. Semenzato Identification of NKp80, a novel triggering molecule expressed by human NK cells Eur J Immunol 31 2003 233 242
8. A. Pessino, S. Sivori, C. Bottino, A. Malaspina, L. Morellil, and L. Moretta Molecular cloning of NKp46: a novel member of the immunoglobulin super family involved in triggering of natural cytotoxicity J Exp Med 188 1998 955 960
9. C. Cantoni, C. Bottino, M. Vitale, A. Pessino, R. Augugliaro, and A. Malaspina NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin super family J Exp Med 189 1999 785 795
10. D. Pende, S. Parolini, A. Pessino, S. Sivovi, R. Augugliaro, and L. Morelli Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells J Exp Med 190 1999 1505 1516
11. S. Sivori, C. Cantoni, S. Parolini, E. Marcenaro, R. Conte, and L. Moretta IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors Eur J Immunol 33 2003 3439 3447
12. G. Ferlazzo, D. Thomas, S. Lin, K. Goodman, B. Morandi, and W.A. Muller The abundant NK cells in human secondary lymphoid tissue require activation to express killer cell Ig-like receptors and become cytolytic J Immunol 172 2004 1455 1462
13. L.E. Jonges, P. Albertsson, R.L.P. vanVlierberghe, N.G. Ensink, B.R. Johansson, and C.J.H. vanDevelde The phenotypic heterogeneity of human natural killer cells: presence of at least 48 different subsets in the peripheral blood Scand J Immunol 53 2001 103 110
14. L.A. Koopman, H.D. Kopcow, B. Rybalow, J.E. Boyson, J.S. Orange, and F. Schatz Human decidual national killer cells are a unique NK cell subset with immunomodulatory potential J Exp Med 198 2003 1201 1212
15. F. Leon, E. Roldan, L. Sanchez, C. Camarero, A. Bootello, and G. Roy Human small intestinal epithelium contains functional natural killer lymphocytes Gastroenterology 125 2003 345 356
16. K.J.L. Hammond, and D.I. Godfrey NKT Cells: potential targets for autoimmune disease therapy Tissue Antigens 159 2002 353 363
17. L. Moretta, C. Romagnani, G. Pietra, A. Moretta, and M.C. Mingari NK-CTLS, a novel HLA-E restricted T cell subset Trends Immunol 24 2003 136 143
18. C. Menier, B. Saez, V. Horejsi, S. Martinozzi, K. Krawice-Radanne, and S. Brael Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA Class I molecules Hum Immunol 64 2003 315 326
19. Y. Matsuo, and H.G. Drexler Immunoprofiling of cell lines derived from natural killer cell and natural killer-like T-cell leukemia lymphoma Leuk Res 27 2003 935 945
20. H.G. Drexler, and Y. Matsuo Malignant hematopoietic cell lines:in vitro models for the study of natural killer cell leukemia-lymphoma Leukemia 14 2000 777 782
21. B.I.S. Srivastava, A. Srivastava, and M.D. Srivastava Phenotype, genotype and cytokine production in acute leukemia involving progenitors of dendritic langerhan's cell Leuk Res 18 1994 499 511
22. M.D. Srivastava, and A.K. Bhargava Expression of dipeptidylammo peptidose-IV in come human T and B cell lines Acta Haemat 76 1986 25 28
23. +) Tlymphocytes responding to lymphocytic choriomeningitis virus in vivo Eur J Immunol 19 1989 151 156
24. + lymphocytes in lymph nodes of human immuno-deficiency virus-1-infected patients Am J Pathol 142 1993 1750 1758
25. M. Tsudo, R.W. Kozak, C.K. Goldman, and T.A. Waldmann Demonstratoin of a non-Tac peptide that binds interleukin 2. A potential participant in a multi-chain interleukin eceptor complex Proc Natl Acad Sci 83 1986 9694 9698
26. B.I.S. Srivastava, C. Gonzales, R. Loftus, J.E. Fitzpatrick, and C.W. Saxinger Examination of HTLV-1 ELISA positive leukemia/lymphoma patients by Western blotting gave mostly negative and undeterminate reaction AIDS Res Hum Retroviruses 6 1990 617 627
27. T. Uemori, K. Asada, I. Kato, and R. Harasawa Amplicatication of the 16S-23S spacer region in RRNA operons of mycoplasmas by the polymerase chain reaction Syst Appl Microbiol 15 1992 181 186
28. M. Uhrberg, N.M. Valiante, B.P. Shum, H.G. Shilling, K. Lienert-Weidenbach, and B. Corliss Human diversity in killer cell inhibitory receptor genes Immunity 7 1997 753 763
29. R. Castriconi, C. Cantoni, M.D. Chiesa, M. Vitale, E. Marcenaro, and R. Conte Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors. Consequences for the NK-mediated killing of dendritic cells Proc Natl Acad Sci 100 2003 4120 4125
30. S.A. Perez, P.A. Sotiropoulou, D.G. Gkika, L.G. Mahaira, D.K. Nicarchos, and A.S. Gritzapis A novel myeloid like NK cell progenitor in human umbilical cord blood Blood 101 2003 3444 3450
31. A.E. Medvedev, A.C. Johnson, J. Haux, B. Steinkger, K. Egeberg, and D.H. Lynch Regulation of Fas and Fas-ligand expression in NK cells by cytokines and involvement of Fas-ligand in NK/LAK cell-mediated cytotoxicity Cytokines 9 1997 394 404
32. B. Gansuvd, M. Hagihara, A. Higuchi, Y. Ueda, K. Tazume, and T. Tsuchiya Umbilical cord blood dendritic cells are a rich source of soluble HLA-DR: synergistic effect of exosomes and dendritic cells on autologous or allogeneic T cell proliferation Hum Immunol 64 2003 427 439
33. M. Inoue, M. Matsuoka, K. Yamaguchi, K. Takatsuki, and M. Yoshinda Characterization of mRNA expression of IKBα and MF-KB subfamilies in primary adult T-cell leukemia cells Jpn J Cancer Res 89 1998 53 59
34. S. Mizuno, T. Chijiwa, T. Okamura, K. Akashi, Y. Fukamaki, and Y. Niho Expression of DNA methyltransferases DNMT 1, 3A and 3B in moral hematopoiesis and in acute and chronic myelogenos leukemia Blood 97 2001 1172 1179
35. A.C. Keates, I. Castagliuolo, W.W. Cruickshank, B. Qui, K.O. Arseneau, and W. Brazer Interleukin-16 is upregulated in Crohn's disease and participates in TNBS colitis in mice Gastroenterology 119 2000 972 982
36. J.D. Marshall, M. Aste-Amezaga, S.S. Chehimi, M. Murphy, H. Olsen, and G. Trinchieri Regulation of human IL-18 mRNA expression Clin Immunol 90 1999 15 21
37. P. Ballerini, A. Blaise, M. Busson-LeConiat, X.Y. Su, J. Zucman-Rossi, and M. Adam A Hox 11 L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis Blood 100 2002 991 997
38. Y. Kanai, S. Ushingima, Y. Dondo, Y. Nakanishi, and S. Hirshashi DNA methyl transferase expression and DNA methylation of CPG islands and peri-centromeric satellite regions in human colorectal and stomach cancers Int J Cancer 91 2001 205 212
39. S.V. Kim, and R.A. Flavell CD8αα and T cell memory Science 304 2004 529 530
40. - bone marrow cells J Immunol 171 2003 683 690
41. Srivastava MD. The modulation of expression of proinflammatory cytokines in human hematopoietic cells. Ph.D. thesis, SUNY Buffalo 1995.
42. M.D. Srivastava, J.L. Ambrus, and B.I.S. Srivastava Cytokine production by normal and malignant human cell lines 17th International cancer congress - Brazil Monduzzi Editore, SPA-Bologna, Italy 1998 115 118
43. M.D. Srivastava, B.I.S. Srivastava, and B. Brouhard Delta-9- tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells Immunopharmacology 40 1998 179 185
44. S.S. Choi, V.S. Chhabra, O.H. Nguyen, B.J. Ank, E.R. Stiehm, and R.R. Roberts Interleukin-15 enhances cytotoxicity receptor expression and expansion of neonatal natural killer cells in long-term culture Clin Diag Lab Immunol 11 2004 879 888
45. S. Yamasaki, N.M. Maeda, K. Ohshimas, M. Kikuchi, T. Otsuka, and M. Haradam Growth and apoptosis of human natural killer cell neoplasms: role of interleukin-2/15 signalling Leuk Res 28 2004 1023 1031
46. + T lymphocytes Int Immunol 14 2002 1085 1098
47. J.M.C. Teng, X.R. Liu, G.B. Mills, and B. Dupont CD28-mediated cytotoxicity by the human leukemic NK cell line YT involves tyrosine phosphorylation, activation of phosphatidyl inositol 3-kinase and protein kinase C J Immunol 156 1996 3222 3232
48. J.H. Gong, G. Maki, and H.G. Klingemann Characterization of human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells Leukemia 8 1994 652 658
49. E. Marcenaro, R. Augigliaro, M. Faico, R. Casticoni, S. Parolini, and S. Sivori CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity Eur J Immunol 33 2003 3367 3376
50. I. Ming Chen, M. Whalen, A. Bankhurst, C.E. Sever, R. Doshi, and D. Hardekopf A new human natural killer leukemia cell line, IMC-1. A complex chromosomal rearrangement defined by spertral karyotyping: functional and cytogenetic characterization Leuk Res 28 2004 275 284
51. M. Yagita, C.L. Huang, H. Umehara, Y. Masuo, R. Tabata, and M. Mivake A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation Leukemia 14 2000 922 930
52. R. O'Connor, A. Cesano, B. Lange, J. Finan, C. Nowell, and S.C. Clark Growth factor requirements of childhood acute T-lymphoblastic leukemia: correlation between presence of chromosomal abnormalities and ability to grow permanently in vitro Blood 77 1991 1534 1545
53. A.A. Maghazachi G protein coupled receptors in natural killer cells J Leukoc Biol 74 2003 16 24
54. M.D. Srivastava, and B.I.S. Srivastava Expression of mRNA and proteins for Toll-like receptors, associated molecules, defensins and LL-37 by SRIK-NKL, a CD8+ NK/T cell line Leuk Res 2004
55. L. Zhang, W. Yu, T. He, J. Yu, R.E. Caffrey, and E.A. Dalmasso Contribution of human α-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor Science 298 2002 995 1000
56. J.A. Levy The search for the CD8+ cell anti-HIV factor (CAF) Trends Immunol 24 2003 628 632